companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2018
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK 730,000 compared with DKK -2,394,000 the year before. Equity amounted to DKK 3,396,000. The solvency ratio was 14.7%.
- Profit/Loss
- 730,000 kr.
- Equity
- 3,396,000 kr.
- Total Assets
- 23,153,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | 730 t. | 3.4 mio. | - |
| 2017 | - | - | -2.4 mio. | 2.7 mio. | - |
| 2016 | - | - | -5.3 mio. | 25.1 mio. | - |
| 2015 | - | - | -5.7 mio. | 40.6 mio. | - |
| 2014 | - | - | -21 t. | 424 t. | - |
Keep an eye on Novo Nordisk North America Operations A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of October 1, 2018, Tomas Haagen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of October 1, 2018, Ole Falvig Ramsby has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2017. The net result was DKK -2,394,000.
As of April 25, 2018, Karsten Munk Knudsen has joined the board of directors of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Jesper Brandgaard has left the board of directors of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Peter Bøggild is registered as director of Novo Nordisk North America Operations A/S.
As of April 25, 2018, Karsten Munk Knudsen has stepped down as director of Novo Nordisk North America Operations A/S.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.